Posts by: Marisa Wexler

More research is needed to develop models of how family caregiving tends to work in Parkinson’s disease and to test interventions aimed at offering support to caregivers. That’s the argument made ... Read more

May 6, 2022May 6, 2022

Medication Side Effects Tied to Higher Blood Transfusion Rates

Parkinson's News Today

People with Parkinson’s disease who experience side effects from their medications are more likely to require a blood transfusion, a new analysis indicates. Digestive problems, particularly bleeding in the gut, ... Read more

May 4, 2022May 4, 2022

Direct-to-brain Levodopa, Curcumin Treatment May Merit Closer Look

Parkinson's News Today

Nanoparticles that simultaneously deliver levodopa and curcumin, a potentially neuroprotective compound, directly to the brain may be “a promising novel therapy for treating Parkinson’s disease,” researchers in Brazil and France ... Read more

May 4, 2022May 4, 2022

Two Exercise Programs Improve Dexterity, Quality of Life: Study

Parkinson's News Today

Two different types of rehabilitation-focused exercise programs — activity-based training and strength exercises — improved measures of dexterity and upper limb function in a small clinical trial of people with ... Read more

May 3, 2022May 3, 2022

High Vitamin D Levels Linked to Fewer Cognitive Problems in Study

Parkinson's News Today

People with Parkinson’s disease who have higher levels of vitamin D in their blood are less likely to experience cognitive impairment or dementia, a new study suggests. The results provide ... Read more

May 2, 2022May 2, 2022

UB-312 Vaccine Well Tolerated by Healthy Adults in Ongoing Trial

Parkinson's News Today

UB-312, an experimental vaccine targeting aggregated and toxic forms of alpha-synuclein to treat Parkinson’s disease, was generally well tolerated at multiple doses in a clinical trial in healthy adults. Study data ... Read more

April 21, 2022April 21, 2022

‘Forced’ Cycling May Best Help Those With More Severe Motor Symptoms

Parkinson's News Today

Parkinson’s patients who have more severe motor symptoms are more likely to derive a benefit from high-cadence dynamic cycling, an analysis of two cycling studies indicates. Findings were in the study ... Read more

April 21, 2022April 21, 2022

Europe Awaits Proposed New Framework for Sharing Health Data

Sanfilippo News

The European Commission is expected to propose a new governing framework for health data next month, called the European Health Data Space (EHDS), with the aim of connecting national health ... Read more

April 20, 2022April 20, 2022

Spine Implants May Help Clear Up Orthostatic Hypotension

Parkinson's News Today

Electrical implants in the spine can clear up feelings of lightheadedness upon standing — the result of a condition called orthostatic hypotension — in people with neurological disorders like Parkinson’s ... Read more

April 18, 2022April 18, 2022

Oral GT-02287 Shows Potential to Support Nerve Cell Health

Parkinson's News Today

Treatment with GT-02287, an experimental oral therapy for Parkinson’s disease, corrected numerous damaging abnormalities associated with Parkinson’s in cell models, according to new data shared at a recent conference. “The data ... Read more

April 12, 2022April 12, 2022

Isolation Due to Pandemic Affected Patients’ Mental Health, Cognition

COVID-19 News, Parkinson's News Today

A loss of social support due to the COVID-19 pandemic is tied to poorer mental health and more severe cognitive problems in people with Parkinson’s disease, a study based on ... Read more

April 8, 2022April 8, 2022

Signs of Aging in the Eyes Tied to Higher Parkinson’s Risk

Parkinson's News Today

Markers of age in the retina — the layer of tissue at the back of the eyeball chiefly responsible for sensing light — can be used to predict the risk ... Read more

April 5, 2022April 5, 2022

#AAN2022 – ND0612 Shows Good Safety Profile After 4+ Years

Parkinson's News Today

ND0612, an investigational formulation of carbidopa/levodopa delivered continuously via a subcutaneous pump, was generally well-tolerated for more than four years of treatment in a Phase 2 clinical trial of Parkinson’s ... Read more

April 4, 2022April 4, 2022

‘Clueless’ Gene May Lead to New Parkinson’s Treatments: Fly Model

Parkinson's News Today

Over-expressing a fly gene called clueless (clu) can lessen mitochondrial defects in fruit fly models of Parkinson’s disease, a new study reveals. The results also showed that CLUH, the human equivalent ... Read more

March 28, 2022March 28, 2022

#AAN2022 – IPX-203 Gives 1.5+ Hours More ‘Good On’ Time Per Dose

Parkinson's News Today

Treatment with oral IPX-203, Amneal Pharmaceuticals’ investigational extended-release carbidopa-levodopa (CD/LD) formulation, reduced “off” time by about 1.5 hours a dose, on average, compared to immediate-release tablets of the medication, according ... Read more